Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease.

Savoldo, Barbara

Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. [electronic resource] - American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons Mar 2005 - 566-72 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1600-6135

10.1111/j.1600-6143.2004.00693.x doi


Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--pharmacology
Child
Child, Preschool
DNA, Viral--metabolism
Epstein-Barr Virus Infections--immunology
Female
Herpesvirus 4, Human--genetics
Humans
Immunity, Cellular--drug effects
Liver Transplantation
Lymphoproliferative Disorders--drug therapy
Male
Rituximab
Time Factors